Nature Search

Erratum: A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents

Hai Wang
Pranay Agarwal
Xiaoming He
Amendments and CorrectionsOpen Access07 Jan 2016
Nature Communications

Volume: 7, P: 1
Author Correction: Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations

Julia A. Yaglom
Yongmei Wang
Michael Y. Sherman
Amendments and CorrectionsOpen Access02 May 2018
Scientific Reports

Volume: 8, P: 1
Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer

Spermine is a polyamine dysregulated in different cancers. This group shows that Serpinb9 prevents spermine synthase degradation, raising spermine levels and impairing the tumor immune microenvironment, and identifying Serpinb9 as a potential therapeutic target for pancreatic cancer immunotherapy.

Hanshen Yang
Xiaozhen Zhang
Xueli Bai
ResearchOpen Access22 Aug 2025
Nature Communications

Volume: 16, P: 1-19
Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

Zhuolong Zhou
Kevin Van der Jeught
Xiongbin Lu
Amendments and Corrections30 Aug 2023
Nature Biomedical Engineering

Volume: 9, P: 281-282
Optical Characteristics of ZnS Passivated CdSe/CdS Quantum Dots for High Photostability and Lasing

Xiongbin Wang
Jiahao Yu
Rui Chen
ResearchOpen Access23 Nov 2018
Scientific Reports

Volume: 8, P: 1-7
Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Jiangsheng Xu
Yunhua Liu
Xiaoming He
Amendments and Corrections17 Jan 2020
Nature Nanotechnology

Volume: 15, P: 342
Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Jiangsheng Xu
Yunhua Liu
Xiaoming He
Amendments and Corrections05 Mar 2019
Nature Nanotechnology

Volume: 14, P: 496
Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Inhibiting POLR2A expression upon siRNA delivery represents a promising therapeutic strategy for triple negative breast cancers characterized by p53 inactivation.

Jiangsheng Xu
Yunhua Liu
Xiaoming He
Research25 Feb 2019
Nature Nanotechnology

Volume: 14, P: 388-397
Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance

The transmembrane P-glycoprotein (P-gp) pumps are known to promote drug resistance by enhancing drug efflux. Here, the authors deliver P-gp inhibitor and a chemotherapeutic agent using tumor blood vessel-targeting nanoparticle, to overcome drug resistance.

Hai Wang
Yutong Liang
Xiaoming He
ResearchOpen Access12 Jan 2021
Nature Communications

Volume: 12, P: 1-14
A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents

Nanoparticles have the potential for enhancing drug delivery; however, low drug encapsulation efficiency and drug loading content limit their application. Here, the authors engineer a complex nanostructure for drug delivery in cancer treatment and evaluate it in different conditions with encouraging results.

Hai Wang
Pranay Agarwal
Xiaoming He
ResearchOpen Access01 Dec 2015
Nature Communications

Volume: 6, P: 1-13
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Heterozygous loss of chromosome 17p is a common genomic event in castration-resistant prostate cancers (CRPC). Here, the authors use CRISPR-based screen to identify RBX1 as a target gene for CRPC with 17p loss and targeting RBX1 sensitizes CRPC to the treatment of α-amanitin antibody conjugates.

Yujing Li
Yunhua Liu
Xiongbin Lu
ResearchOpen Access22 Oct 2018
Nature Communications

Volume: 9, P: 1-15
Lipid droplet-associated lncRNA LIPTER preserves cardiac lipid metabolism

Han et al. identify the long non-coding RNA LIPTER as a key mediator of lipid droplet transport and metabolism in human cardiomyocytes. LIPTER overexpression mitigates cardiomyopathy and preserves cardiac function in obese and diabetic mouse models.

Lei Han
Dayang Huang
Lei Yang
ResearchOpen Access01 Jun 2023
Nature Cell Biology

Volume: 25, P: 1033-1046
Solution-processed upconversion photodetectors based on quantum dots

By embedding silver nanoparticles in the electron transport layer, solution-processed quantum-dot-based photodetectors with a high photon-to-electron conversion efficiency of 6.5% and a low turn-on voltage of 2.5 V can be created for use in infrared imaging applications.

Wenjia Zhou
Yuequn Shang
Zhijun Ning
Research30 Mar 2020
Nature Electronics

Volume: 3, P: 251-258
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

Epigenetic inhibitors that promote antigen presentation and potentiate T-cell-mediated cytotoxicity can be identified by a high-throughput screen of cytotoxic T-cell activity in breast tumour organoids.

Zhuolong Zhou
Kevin Van der Jeught
Xiongbin Lu
Research01 Nov 2021
Nature Biomedical Engineering

Volume: 5, P: 1320-1335
p53 mutant mice that display early ageing-associated phenotypes

Stuart D. Tyner
Sundaresan Venkatachalam
Lawrence A. Donehower
Research03 Jan 2002
Nature

Volume: 415, P: 45-53
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

The 17q23 amplicon containing the WIP1 oncogene is frequently amplified in HER2+ breast cancer. Here they find MIR21 to be present in WIP1-containing amplicons, and report nanoparticle based co-delivery of WIP1 and miR-21 inhibitors to be effective in trastuzumab-resistant HER2+ breast cancer.

Yunhua Liu
Jiangsheng Xu
Xinna Zhang
ResearchOpen Access09 Nov 2018
Nature Communications

Volume: 9, P: 1-16
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance

Multidrug resistance is a major challenge in cancer therapy. Here, the authors develop a mitochondria-targeting nanoparticle system that inhibits adenosine triphosphate transporter activity via reactive oxygen species generation and can thus be used to target multidrug-resistant cancer.

Hai Wang
Zan Gao
Xiaoming He
ResearchOpen Access08 Feb 2018
Nature Communications

Volume: 9, P: 1-16
Zuogui Wan modulates macrophage polarization and promotes osteogenic differentiation through regulation of CD51-positive bone marrow mesenchymal stem cells

Chongyang Shen
Mingxing Deng
Yincong Liu
ResearchOpen Access30 Oct 2024
Scientific Reports

Volume: 14, P: 1-18
Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations

Julia A. Yaglom
Yongmei Wang
Michael Y. Sherman
ResearchOpen Access14 Feb 2018
Scientific Reports

Volume: 8, P: 1-12
USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model

Juntae Kwon
Hyeongjwa Choi
Cecil Han
ResearchOpen Access16 Feb 2022
Oncogene

Volume: 41, P: 1974-1985
Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma

Chuanpeng Dong
Annamaria Cesarano
Yunlong Liu
ResearchOpen Access09 Sept 2021
Oncogene

Volume: 40, P: 6130-6138

Search

Erratum: A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents

Author Correction: Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations

Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer

Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

Optical Characteristics of ZnS Passivated CdSe/CdS Quantum Dots for High Photostability and Lasing

Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance

A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Lipid droplet-associated lncRNA LIPTER preserves cardiac lipid metabolism

Solution-processed upconversion photodetectors based on quantum dots

An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

p53 mutant mice that display early ageing-associated phenotypes

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance

Zuogui Wan modulates macrophage polarization and promotes osteogenic differentiation through regulation of CD51-positive bone marrow mesenchymal stem cells

Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations

USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model

Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma

Search

Quick links

Search

Filter By:

Search

Quick links